MX337864B - Metodo mejorado para producir analgesicos. - Google Patents
Metodo mejorado para producir analgesicos.Info
- Publication number
- MX337864B MX337864B MX2009006283A MX2009006283A MX337864B MX 337864 B MX337864 B MX 337864B MX 2009006283 A MX2009006283 A MX 2009006283A MX 2009006283 A MX2009006283 A MX 2009006283A MX 337864 B MX337864 B MX 337864B
- Authority
- MX
- Mexico
- Prior art keywords
- oxymorphone hydrochloride
- analgesics
- making
- improved method
- oxymorphone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Abstract
Un analgésico mejorado de clorhidrato de oximorfona contiene menos de 10 ppm de cetonas alfa, beta insaturadas y preparaciones farmacéuticas que comprenden ese clorhidrato de oximorfona. El clorhidrato de oximorfona es producir reduciendo una materia prima de clorhidrato de oximorfona usando hidrógeno gaseosos y bajo acidez específica, un sistema de solventes y condiciones de temperatura específicas. Un polimorfo específico clorhidrato de oximorfona puede ser obtenido por hidratación.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0624880.1A GB0624880D0 (en) | 2006-12-14 | 2006-12-14 | Improved method for making analgesics |
PCT/GB2007/050758 WO2008072018A1 (en) | 2006-12-14 | 2007-12-14 | Improved method for making analgesics |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2009006283A MX2009006283A (es) | 2009-10-12 |
MX337864B true MX337864B (es) | 2016-03-23 |
Family
ID=37712066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009006283A MX337864B (es) | 2006-12-14 | 2007-12-14 | Metodo mejorado para producir analgesicos. |
Country Status (13)
Country | Link |
---|---|
US (1) | US7851482B2 (es) |
EP (1) | EP2102213A1 (es) |
JP (2) | JP4786748B2 (es) |
CN (2) | CN102391271B (es) |
AU (1) | AU2007331223B2 (es) |
BR (1) | BRPI0720232A2 (es) |
CA (1) | CA2672644A1 (es) |
GB (1) | GB0624880D0 (es) |
MX (1) | MX337864B (es) |
NO (1) | NO20092503L (es) |
RU (1) | RU2422445C2 (es) |
WO (1) | WO2008072018A1 (es) |
ZA (1) | ZA200904317B (es) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US8871779B2 (en) * | 2006-03-02 | 2014-10-28 | Mallinckrodt Llc | Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds |
US20080125592A1 (en) * | 2006-10-17 | 2008-05-29 | Penick Corporation | Process for preparing oxymorphone, naltrexone, and buprenorphine |
AU2007313103C1 (en) | 2006-10-17 | 2014-01-30 | Penick Corporation | Process for preparing oxymorphone |
CA2674915C (en) | 2006-10-17 | 2015-06-30 | Penick Corporation | Process for preparing oxymorphone |
DE102007011485A1 (de) * | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
CA2681740A1 (en) * | 2007-03-23 | 2008-10-02 | Mallinckrodt Inc. | Improved preparation of oxymorphone from oripavine |
CA2684458A1 (en) * | 2007-04-16 | 2008-10-30 | Mallinckrodt Inc. | Novel opiate reduction utilizing catalytic hydrogen transfer reaction |
FR2923484B1 (fr) * | 2007-11-09 | 2012-11-09 | Sanofi Aventis | Procede de preparation de composes morphiniques |
NZ586792A (en) | 2008-01-25 | 2012-09-28 | Gruenenthal Chemie | Tamper resistant controlled release pharmaceutical tablets form having convex and concave surfaces |
ES2599031T3 (es) | 2008-05-09 | 2017-01-31 | Grünenthal GmbH | Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización |
AU2010275753B2 (en) * | 2009-07-22 | 2014-08-21 | Grünenthal GmbH | Hot-melt extruded controlled release dosage form |
US20110020451A1 (en) | 2009-07-22 | 2011-01-27 | Grunenthal Gmbh | Tamper-resistant dosage form for oxidation-sensitive opioids |
CA2802295C (en) | 2010-06-11 | 2016-09-20 | Rhodes Technologies | Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof |
ES2537610T3 (es) | 2010-06-11 | 2015-06-10 | Rhodes Technologies | Proceso para la N-desalquilación de aminas terciarias |
US8563571B2 (en) | 2010-07-22 | 2013-10-22 | Noramco, Inc. | Crystalline forms of oxymorphone hydrochloride |
EP2420503A1 (en) * | 2010-07-27 | 2012-02-22 | Universität Innsbruck | Process for the synthesis of 14-oxygenated morphinan-6-ones |
EP2611425B1 (en) | 2010-09-02 | 2014-07-02 | Grünenthal GmbH | Tamper resistant dosage form comprising an anionic polymer |
CN103269688A (zh) | 2010-09-02 | 2013-08-28 | 格吕伦塔尔有限公司 | 包含无机盐的抗破碎剂型 |
WO2012151669A1 (en) | 2011-05-06 | 2012-11-15 | Brock University | Process for the preparation of morphine analogs via metal catalyzed n-demethylation/functionalization and intramolecular group transfer |
WO2012163796A1 (en) | 2011-05-27 | 2012-12-06 | Grünenthal GmbH | Crystalline, anhydrous forms of oxymorphone hydrochloride |
ES2655900T3 (es) | 2011-07-29 | 2018-02-22 | Grünenthal GmbH | Pastilla a prueba de manipulación que proporciona una liberación inmediata de un medicamento |
HUE034710T2 (hu) | 2011-07-29 | 2018-02-28 | Gruenenthal Gmbh | Visszaéléssel szemben ellenálló, azonnali hatóanyagfelszabadulást biztosító tabletta |
WO2013127831A1 (en) | 2012-02-28 | 2013-09-06 | Grünenthal GmbH | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
SI2838512T1 (sl) | 2012-04-18 | 2018-11-30 | Gruenenthal Gmbh | Pred posegi in prehitrim sproščanjem odporna farmacevtska oblika odmerka |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
US9657029B2 (en) | 2012-06-11 | 2017-05-23 | Siegfried Generics International Ag | Method of preparing oxymorphone |
PL2872121T3 (pl) | 2012-07-12 | 2019-02-28 | SpecGx LLC | Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania |
KR101946104B1 (ko) | 2012-07-16 | 2019-02-08 | 로드스 테크놀로지즈 | 개선된 오피오이드 합성을 위한 방법 |
JP6236447B2 (ja) | 2012-07-16 | 2017-11-22 | ローズ テクノロジーズ | 改善されたオピオイド合成方法 |
CN103113378B (zh) * | 2013-02-20 | 2016-04-06 | 北京华素制药股份有限公司 | 一种盐酸羟吗啡酮的合成方法 |
WO2014191396A1 (en) | 2013-05-29 | 2014-12-04 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
BR112015026549A2 (pt) | 2013-05-29 | 2017-07-25 | Gruenenthal Gmbh | forma de dosagem à prova de violação contendo uma ou mais partículas |
CN105682643B (zh) | 2013-07-12 | 2019-12-13 | 格吕伦塔尔有限公司 | 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型 |
GB201313211D0 (en) | 2013-07-24 | 2013-09-04 | Cambrex Karlskoga Ab | New process |
AU2014298257B2 (en) * | 2013-08-02 | 2016-11-10 | Macfarlan Smith Limited | Process for the preparation of oxymorphone |
GB201313915D0 (en) * | 2013-08-02 | 2013-09-18 | Johnson Matthey Plc | Process |
MX371372B (es) | 2013-11-26 | 2020-01-28 | Gruenenthal Gmbh | Preparacion de una composicion farmaceutica en polvo por medio de criomolienda. |
ES2672795T3 (es) * | 2014-01-15 | 2018-06-18 | Rhodes Technologies | Proceso para la síntesis mejorada de oximorfona |
JP2017502991A (ja) | 2014-01-15 | 2017-01-26 | ローズ テクノロジーズ | 改良されたオキシコドン合成のための方法 |
US9062063B1 (en) | 2014-03-21 | 2015-06-23 | Johnson Matthey Public Limited Company | Forms of oxymorphone hydrochloride |
AU2015261060A1 (en) | 2014-05-12 | 2016-11-03 | Grunenthal Gmbh | Tamper resistant immediate release capsule formulation comprising Tapentadol |
US9872835B2 (en) | 2014-05-26 | 2018-01-23 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
MA40332A (fr) * | 2014-07-09 | 2021-04-28 | Rhodes Tech | Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane |
US20160052932A1 (en) * | 2014-08-25 | 2016-02-25 | Johnson Matthey Public Limited Company | Processes for Making Opioids Including 14-Hydroxycodeinone and 14-hydroxymorphinone |
US9918979B2 (en) | 2015-01-29 | 2018-03-20 | Johnson Matthey Public Limited Company | Process of preparing low ABUK oxymorphone hydrochloride |
MX2017013637A (es) | 2015-04-24 | 2018-03-08 | Gruenenthal Gmbh | Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes. |
US20160340362A1 (en) * | 2015-05-20 | 2016-11-24 | Noramco, Inc. | Process For The Preparation Of Oxymorphone Freebase |
GB201513203D0 (en) | 2015-07-27 | 2015-09-09 | Cambrex Charles City Inc | New process |
JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
ES2701855T3 (es) | 2016-05-31 | 2019-02-26 | Alcaliber Investig Desarrollo E Innovacion Slu | Proceso para la obtención de 3,14-diacetiloximorfona a partir de oripavina |
EP3642207B1 (en) * | 2017-06-20 | 2022-08-31 | Johnson Matthey Public Limited Company | Hydrogenation process for preparing oxycodone hydrochloride from 14-hydroxycodeinone |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB717008A (en) * | 1951-05-29 | 1954-10-20 | Mozes Juda Lewenstein | Morphine derivative |
US3474101A (en) * | 1960-09-05 | 1969-10-21 | Reckitt & Sons Ltd | Thebaine and oripavine derivatives |
US3332950A (en) * | 1963-03-23 | 1967-07-25 | Endo Lab | 14-hydroxydihydronormorphinone derivatives |
GB1317210A (en) * | 1970-12-11 | 1973-05-16 | Macarlan Smith Ltd | Reduction of thebaine |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
US4063064A (en) * | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
US4861598A (en) * | 1986-07-18 | 1989-08-29 | Euroceltique, S.A. | Controlled release bases for pharmaceuticals |
DE3812567A1 (de) * | 1988-04-15 | 1989-10-26 | Basf Ag | Verfahren zur herstellung pharmazeutischer mischungen |
FR2636330B1 (fr) * | 1988-09-13 | 1990-11-30 | Sanofi Sa | Procede de preparation de derives de morphinane |
US5215758A (en) * | 1991-09-11 | 1993-06-01 | Euroceltique, S.A. | Controlled release matrix suppository for pharmaceuticals |
US5286493A (en) * | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
US5273760A (en) * | 1991-12-24 | 1993-12-28 | Euroceltigue, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5472712A (en) * | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
US5324351A (en) * | 1992-08-13 | 1994-06-28 | Euroceltique | Aqueous dispersions of zein and preparation thereof |
IL107400A0 (en) * | 1992-11-10 | 1994-01-25 | Cortech Inc | Bradykinin antagonists |
AU3075197A (en) * | 1996-05-21 | 1997-12-09 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Novel methods of o-demethylation and n-deprotection |
US6067749A (en) * | 1996-07-11 | 2000-05-30 | Tasmanian Alkaloids Pty. Ltd. | Papaver somniferum strain with high concentration of thebaine and oripavine |
US5869669A (en) * | 1996-07-26 | 1999-02-09 | Penick Corporation | Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates |
GB9713703D0 (en) * | 1997-06-30 | 1997-09-03 | Johnson Matthey Plc | Preparation of opiates |
GB9717629D0 (en) * | 1997-08-21 | 1997-10-22 | Johnson Matthey Plc | Removal of residual organic solvents |
US6177567B1 (en) | 1999-10-15 | 2001-01-23 | Boehringer Ingelheim Chemicals, Inc. | Method for preparing oxycodone |
ES2292775T3 (es) * | 2001-07-06 | 2008-03-16 | Penwest Pharmaceuticals Co. | Formulaciones de liberacion prolongada de oximorfona. |
WO2003004032A1 (en) * | 2001-07-06 | 2003-01-16 | Endo Pharmaceuticals, Inc. | Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
US7973064B2 (en) * | 2001-11-27 | 2011-07-05 | The Board Of Trustees Of The University Of Illinois | Method and composition for potentiating an opiate analgesic |
US6864370B1 (en) * | 2003-06-05 | 2005-03-08 | Zhaiwei Lin | Process for manufacturing oxycodone |
WO2005028483A1 (en) | 2003-09-22 | 2005-03-31 | Glaxosmithkline Australia Pty Ltd | Process for the synthesis of morphinane compounds and intermediates thereof |
US7875718B2 (en) * | 2003-09-22 | 2011-01-25 | Johnson Matthey Public Limited Company | Process for the synthesis of morphinane compounds and intermediates thereof |
TWI483944B (zh) * | 2004-03-30 | 2015-05-11 | Euro Celtique Sa | 含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝 |
US6949645B1 (en) * | 2004-05-20 | 2005-09-27 | Acura Pharmaceuticals, Inc. | Process for the production of opiates |
WO2006005112A1 (en) * | 2004-07-09 | 2006-01-19 | Tasmanian Alkaloids Pty Ltd | Process for the synthesis of hydromorphone |
GB0421149D0 (en) * | 2004-09-23 | 2004-10-27 | Johnson Matthey Plc | Preparation of oxycodone |
WO2006084389A1 (de) * | 2005-02-11 | 2006-08-17 | Cilag Ltd. | Verfahren zur reinigung von noroxymorphon-verbindungen |
US8871779B2 (en) * | 2006-03-02 | 2014-10-28 | Mallinckrodt Llc | Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds |
US20080125592A1 (en) * | 2006-10-17 | 2008-05-29 | Penick Corporation | Process for preparing oxymorphone, naltrexone, and buprenorphine |
-
2006
- 2006-12-14 GB GBGB0624880.1A patent/GB0624880D0/en not_active Ceased
-
2007
- 2007-10-03 US US11/866,840 patent/US7851482B2/en not_active Expired - Fee Related
- 2007-12-14 AU AU2007331223A patent/AU2007331223B2/en not_active Ceased
- 2007-12-14 WO PCT/GB2007/050758 patent/WO2008072018A1/en active Application Filing
- 2007-12-14 RU RU2009126774/04A patent/RU2422445C2/ru not_active IP Right Cessation
- 2007-12-14 EP EP07848718A patent/EP2102213A1/en not_active Withdrawn
- 2007-12-14 CA CA002672644A patent/CA2672644A1/en not_active Abandoned
- 2007-12-14 CN CN201110334801.8A patent/CN102391271B/zh not_active Expired - Fee Related
- 2007-12-14 CN CN200780051132A patent/CN101652371A/zh active Pending
- 2007-12-14 ZA ZA200904317A patent/ZA200904317B/xx unknown
- 2007-12-14 BR BRPI0720232-6A2A patent/BRPI0720232A2/pt not_active Application Discontinuation
- 2007-12-14 JP JP2009540878A patent/JP4786748B2/ja not_active Expired - Fee Related
- 2007-12-14 MX MX2009006283A patent/MX337864B/es active IP Right Grant
-
2009
- 2009-07-02 NO NO20092503A patent/NO20092503L/no not_active Application Discontinuation
-
2011
- 2011-05-27 JP JP2011118861A patent/JP2011201906A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20080146601A1 (en) | 2008-06-19 |
JP4786748B2 (ja) | 2011-10-05 |
GB0624880D0 (en) | 2007-01-24 |
AU2007331223B2 (en) | 2010-08-26 |
JP2011201906A (ja) | 2011-10-13 |
MX2009006283A (es) | 2009-10-12 |
AU2007331223A1 (en) | 2008-06-19 |
JP2010513260A (ja) | 2010-04-30 |
US7851482B2 (en) | 2010-12-14 |
CN102391271B (zh) | 2015-12-09 |
RU2009126774A (ru) | 2011-01-20 |
RU2422445C2 (ru) | 2011-06-27 |
CA2672644A1 (en) | 2008-06-19 |
WO2008072018A1 (en) | 2008-06-19 |
BRPI0720232A2 (pt) | 2013-12-24 |
NO20092503L (no) | 2009-08-27 |
CN102391271A (zh) | 2012-03-28 |
CN101652371A (zh) | 2010-02-17 |
ZA200904317B (en) | 2010-08-25 |
EP2102213A1 (en) | 2009-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX337864B (es) | Metodo mejorado para producir analgesicos. | |
MX2008015731A (es) | Tabletas sublinguales de baja dosificacion de analgesicos opiaiceos y proceso de preparacion. | |
IN2015DN01813A (es) | ||
GEP20074135B (en) | Process for the synthesis of (is)-4,5-dimethoxy-1-(methylaminomethyl)- benzocyclobutane and addition salts thereof, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
SI1881967T1 (sl) | Substituirane benzo(d)izoksazol-3-il-aminske spojine kot analgetiki | |
MX2009001072A (es) | Proceso de sintesis de macrolido. | |
WO2008146308A3 (en) | Process for the preparation of ivabradine hydrochloride and polymorph thereof | |
DK2079706T3 (da) | Fremgangsmåde til fremstilling af medetomidin og saltene deraf | |
WO2007137785A3 (en) | Process useful in the preparation of morphinan antagonists | |
EP2026901A4 (en) | SUPERCRITICAL PROCESS, REACTOR AND SYSTEM FOR PRODUCING HYDROGEN | |
UA98303C2 (ru) | Способ синтеза макролидов | |
UA83152C2 (ru) | Твердая фармацевтическая композиция, содержащая донепезила гидрохлорид | |
WO2009027249A3 (de) | Verfahren zur herstellung von aminen aus zuckeralkoholen | |
MY144180A (en) | Method for producing strontium ranelate and its hydrates | |
UA94837C2 (ru) | Способ синтеза (7-метокси-1-нафтил)ацетонитрила и применение в синтезе агомелатина | |
EP1985371A4 (en) | FUNIGZID PROCESSES ABOUT CONIDIUM ADSORPTION USING DIELECTRIC POLARIZATION DEVICE FOR ELIMINATING FLYING ORGANISMS AND DEVICE FOR PROTECTING PLANTS | |
WO2007006732A8 (en) | Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist) | |
UA97648C2 (ru) | N-(2-гидроксиэтил)-n-метил-4-(хинолин-8-ил(1-(тиазол-4-илметил)пиперидин-4-илиден)метил)бензамид, способ его получения (варианты), фармацевтическая композиция и его применение для подавления боли или для лечения депрессии, тревожности или болезни паркинсона | |
AP2277A (en) | Process for production of 1,2,2,2-tertafluoro ethyl difluoro methyl ether. | |
HK1119658A1 (en) | Method for producing acetoacetic acid arylamides | |
UA99725C2 (ru) | Способ получения 5-бензилокси-2-(4-бензилоксифенил)-3-метил-1н-индола | |
MX2009007598A (es) | Hexahidrato de enrofloxacino. | |
MX2013007970A (es) | Procedimiento para la preparacion de 2,2-difluoroetilamina a partir de 2,2-difluoro-1-cloroetano y amoniaco. | |
GEP20156350B (en) | New process for synthesis of ivabradine and their additional salts with pharmaceutically acceptable acid | |
MX2009004648A (es) | Proceso para la preparacion de 2,5-bis-(2,2,2-trifluoroetoxi)-n-(2 -piperidilmetil)-benzamida y sales de la misma. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |